ruramayi rukuni - Infectious Diseases

Author Information

Ruramayi Rukuni is a researcher affiliated with the National Perinatal Epidemiology Unit at the University of Oxford, located in Old Road, Campus, Oxford, UK. Her work primarily focuses on the impact of HIV infection on growth, development, and comorbidities in children and adolescents, particularly in the context of sub-Saharan Africa. Her studies often explore the effects of antiretroviral therapy on skeletal development and other health outcomes in HIV-infected populations.

Research Contributions

Ruramayi Rukuni has made significant contributions to the field of infectious diseases, with a particular emphasis on the effects of HIV infection in children and adolescents. Her research has provided valuable insights into how HIV and antiretroviral therapy influence growth, bone density, and chronic comorbidities in peripubertal children. Notable studies include cross-sectional studies in Zimbabwe and prospective cohort studies like the IMVASK Study, which investigates the impact of vertical HIV infection on skeletal development. Additionally, she has explored the social and functional implications of living with HIV for older children in Zimbabwe, as well as issues related to maternal and neonatal health outcomes.

Aliases

There are no aliases listed for Ruramayi Rukuni.

Publication and Citation Metrics

Metric	Value
Total Number of Papers	14
Total Citation Count	186
H-index	7

Publications:

Effect of HIV Infection on Growth and Bone Density in Peripubertal Children in the Era of Antiretroviral Therapy: A Cross-Sectional Study in Zimbabwe

DOI: 10.2139/SSRN.3786703

Year: 2021

Effect of HIV infection on growth and bone density in peripubertal children in the era of antiretroviral therapy: a cross-sectional study in Zimbabwe

DOI: 10.1016/S2352-4642(21)00133-4

Year: 2021

Chronic comorbidities in children and adolescents with perinatally acquired HIV infection in sub-Saharan Africa in the era of antiretroviral therapy.

DOI: 10.1016/S2352-4642(20)30037-7

Year: 2020

The IMpact of Vertical HIV infection on child and Adolescent SKeletal development in Harare, Zimbabwe (IMVASK Study): a protocol for a prospective cohort study

DOI: 10.1136/bmjopen-2019-031792

Year: 2020

Older age at initiation of antiretroviral therapy predicts low bone mineral density in children with perinatally-infected HIV in Zimbabwe

DOI: 10.1016/j.bone.2019.05.012

Year: 2019

Older age at Initiation of Antiretroviral Therapy Predicts Low Bone Mineral Density in Children with perinatally-infected HIV in Zimbabwe

DOI: 10.1101/565143

Year: 2019

The impact of HIV infection on bone and muscle development in Zimbabwean children

DOI: 10.1186/isrctn12266984

Year: 2019

Disability, social functioning and school inclusion among older children and adolescents living with HIV in Zimbabwe

DOI: 10.1111/tmi.13012

Year: 2018

Ending eclampsia: Kenya. Exploring opportunities for preventing and managing pre-eclampsia / eclampsia.

DOI: 10.1007/S00103-018-2703-5

Year: 2018

Maternal and neonatal outcomes of antenatal anemia in a Scottish population: a retrospective cohort study

DOI: 10.1111/aogs.12862

Year: 2016

Why is the Global Fund Important?

What are Healthcare Associated Infections (HAIs)?

What is AIDS?

How is Avian Influenza Diagnosed?

What is Vector Borne Transmission?

What is Efficacy?

How to ensure the reliability of RT-PCR results?

How are DAAs used in combination therapies?

What is Mycobacterium Tuberculosis?

How to Choose the Right Antimalarial Drug?

Partnered Content Networks

Relevant Topics